Patent · US Active

Lentiviral vectors containing an MHC class I, MHC class II, or B2 microglobulin upstream promoter sequence

US9657311B2 · kind B2 · utility

3Cited by

0References

21Claims

0Family size

Assignee

THERAVECTYS · FR

Inventors

Cecile Bauche · Paris, FR
Emeline Sarry · Malakoff, FR

Key dates

Filing date	May 27, 2014
Grant date	May 23, 2017
Priority date	—
Expiry date	May 27, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2830/85
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the insertion of an MHC class I, MHC Class II, or β2 microglobulin upstream promoter sequence into a lentiviral vector to increase viral titers. The invention encompasses these vectors, methods of making the vectors, and methods of using them, including medicinal uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.